News

SHAREHOLDER WARNING: Pomerantz regulation agency is investigating claims on behalf of traders in Vaxart, Inc. -VXRT – Yahoo Finance

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "NEW YORK, August 29, 2020 (GLOBE NEWSWIRE) – Pomerantz LLP is investigating claims on behalf of investors of Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAQ: VXRT), and those investors are encouraged to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980.
"data-reactid =" 12 "> NEW YORK, Aug 29, 2020 (GLOBE NEWSWIRE) – Pomerantz LLP is investigating claims on behalf of investors of Vaxart, Inc. (" Vaxart "or the" Company ") (NASDAQ: VXRT). It is recommended that such investors contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Vaxart and any of its officers and / or directors have committed securities fraud or other illegal business practices.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "(Click here for information on how to participate in the class action.)"data-reactid =" 14 ">(Click here for information on how to participate in the class action.)

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "On July 25th, 2020 the New York Times published an article titled "Corporate Insiders Pocket $ 1 Billion In A Hurry For Coronavirus Vaccine". The New York Times An article reported that Vaxarts "(c) company insiders who had received several million dollars worth of stock options weeks earlier increased the value of those awards six times" when the company announced that its COVID-19 vaccine was from the US -Government had been selected to be part of Operation Warp Speed, the flagship federal initiative to rapidly develop drugs to combat COVID-19. "data-reactid =" 19 "> On July 25, 2020, the New York Times published an article entitled" Corporate Insiders Pocket $ 1 Billion In A Hurry For Coronavirus Vaccines. "The New York Times article reported that Vaxarts "(c) company insiders who received several million dollars worth of stock options weeks earlier increased the value of those awards six times" when the company announced that its COVID-19 vaccine had been selected by the US government as part of Operation Warp Speed, the federal flagship initiative to rapidly develop drugs to combat COVID-19.

In the news, Vaxart's share price fell $ 1.13 per share, or 9.19%, to close at $ 11.16 per share on July 27, 2020.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "The company Pomerantz with offices in New York, Chicago, Los Angeles and Paris are recognized as a premier corporate, securities and antitrust litigation firm. Founded by the late Abraham L. Pomerantz, best known as the dean of class action, the Pomerantz Firm Today, more than 80 years later, Pomerantz continues Continuing its tradition of fighting for the rights of victims of securities fraud, fiduciary violations, and corporate misconduct, the company has recovered from numerous tens of millions of dollars in damages paid on behalf of class members www.pomerantzlaw.com. "data-reactid =" 21 "> The Pomerantz company with offices in New York, Chicago, Los Angeles and Paris is one of the leading companies in the areas of corporate, securities and antitrust disputes. Founded by the late Abraham L. Pomerantz, Known as the dean of the class action lawsuit, pioneered the Pomerantz Company. Today, more than 80 years later, the Pomerantz Company continues its tradition of fighting for the rights of victims of securities fraud, fiduciary violations and corporate misconduct has filed numerous multi-million dollar claims for damages on behalf of class members, see www.pomerantzlaw.com.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 extension 7980 "data-reactid =" 22 ">CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 ext. 7980

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "
"data-reactid =" 23 ">

0 Comments
Share

labsurlab

Reply your comment

Your email address will not be published. Required fields are marked*